Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medical Device and Diagnostic Industry (MD+DI)

Medtronic’s Tiny Defibrillation Lead Packs a Big Punch

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...

Decoding Slow Heart Rhythms: Dr Ranjan Shetty Explains the Impact of Bradycardia and Advances in Pacemaker Care

Bradycardia is typically defined as a heart rate below 60 beats per minute. While this may be perfectly normal for athletes or physically fit individuals, it can signal a malfunct ...
Fierce Biotech

Medtronic, Biotronik heart hardware make strides in conduction system pacing

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
Medical Device and Diagnostic Industry (MD+DI)

Iconic TV Show Predicts Boston Scientific’s Pacemaker Battery Problem — in 1992

Explore how a 1992 Law & Order episode eerily mirrors Boston Scientific's real-life pacemaker battery issues, raising ...

HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...
MassDevice

Biotronik kicks off study of leadless pacemaker, announces first commercial implant of LBBAP lead

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

Medtronic plc: Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...

Medtronic’s OmniaSecure defib lead nets another FDA approval

Irish medtech giant Medtronic has secured another US approval for its OmniaSecure defibrillation lead, expanding its use to ...
MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...